A Plus Inc. (A+) is a leading regional CRO in Asia Pacific, dedicated to assist the pharmaceutical and biotechnology industry with drug to market processes. With site offices across Taiwan, China, Japan, Korea and other Asian countries, A+ is offering the one-stop service tailored to the need of the late phase Asia-Pacific regional trials.
As a part of the Protech Pharmaservices Corporation established in 1997, our accumulated experience and profound expertise in all clinical trial related services, including, but not limited to, clinical study monitoring, project management, data management, statistical data analysis, protocols, and reports, offering high quality, cost effective, and time reduced solutions in the clinical development for products or devices.

As a CRO, we are fully compliant with international ICH-GCP standards using cutting edge computer software and technologies to assure the fidelity and efficacy of the trial.

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2.2 billion and more than 11,000 employees in over 60 countries.

With the most comprehensive portfolio of preclinical, clinical development and commercialization services, Covance provides industry-leading services, the world’s largest central laboratory network, and a global team of clinical trial and commercialization experts.

LabCorp Clinical Trials is a division of Laboratory Corporation of America(r) Holdings (NYSE: LH), one of the world's largest clinical laboratories with annual revenues of $5.5 billion in 2011 and more than 220,000 clients. LabCorp Clinical Trials supports pharmaceutical companies with innovative laboratory services for their global clinical trial programs. We provide laboratory testing at our wholly owned central labs in Belgium, China, Singapore and the USA - including Phase I-IV trials, esoteric testing, biomarker development and validation, new method development and companion diagnostics.

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naïve geographies, leveraging decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection. Our team members, technologies and network of facilities bridge the distance between patients and the essential resources of life science companies.

Jubilant Clinsys  is a scientifically focused contract research organization that provides pharmaceutical, biotechnology and medical device companies with a full range of services in support of Phase I – IV drug and device development. The company is a subsidiary of Jubilant Life Sciences and a fully integrated partner with Jubilant Biosys and Jubilant Chemsys. Founded in 1992, the company operates globally at offices in Bedminster, New Jersey, USA; Raleigh, North Carolina, USA; Ottawa, Ontario; Canada, Noida and Bangalore, India and Dusseldorf, Germany. Jubilant Clinsys carefully selects its strategic alliance partners to continuously strengthen its worldwide operations. The net value of our alliances gives our sponsors enhanced patient recruitment options, local expertise and one point of contact. Each partner has a clinical focus that enables Clinsys to meet the unique demands of individual projects. Harmonized standard operating procedures (SOPs) are utilized with all partners.

As the industry leader in cardiac safety drug research, respiratory research and multi-mode ePRO solutions ERT (www.ERT.com) has provided unparalleled scientific and regulatory leadership to biopharmaceutical, Contract Research Organizations (CROs) and medical device companies — around the globe. ERT is the one experienced partner to turn to for best-in-class solutions and best-in-class advisement, whenever you need to collect and manage clinical data to deliver quality results that support getting your new drugs to market. It’s time to let ERT put our experience to work for you.

Bentham Science Publishers, a major STM journal publisher of 61 titles in 2005, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Pharmaceutical Design (Impact Factor 5.55) and Current Medicinal Chemistry.

CanBiotech is an open innovation platform for the biotechnology and pharmaceutical industries. Source new partners through the CanBiotech portal, participate in our open innovation training workshops in partnership with BioEndeavor and engage CanBiotech and its network of partners to enable open innovation in your organization. Publications include Bio Partnerships Asia©. www.canbiotech.com

Clinical Leader is an online community that helps streamline clinical research by connecting trial sponsors and cutting edge service providers. In browsing the site, users can view and download a variety of industry-related content from our supplier directory, product showcase, and resource centers. This content is designed to help sponsors select potential partners and products to aid in clinical research.

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.

Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.

LabCorp Clinical Trials is a division of Laboratory Corporation of America(r) Holdings (NYSE: LH), one of the world's largest clinical laboratories with annual revenues of $5.5 billion in 2011 and more than 220,000 clients. LabCorp Clinical Trials supports pharmaceutical companies with innovative laboratory services for their global clinical trial programs. We provide laboratory testing at our wholly owned central labs in Belgium, China, Singapore and the USA - including Phase I-IV trials, esoteric testing, biomarker development and validation, new method development and companion diagnostics.

www.praintl.com

http://www.wuxiapptec.com/